Privia Health Group, Inc. (NASDAQ:PRVA) Director Sells $454,369.59 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) Director William M. Sullivan sold 18,153 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $25.03, for a total transaction of $454,369.59. Following the completion of the sale, the director now owns 5,510,484 shares of the company’s stock, valued at approximately $137,927,414.52. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Privia Health Group Trading Down 3.7 %

NASDAQ PRVA traded down $0.87 during trading on Tuesday, hitting $22.72. 1,396,107 shares of the company traded hands, compared to its average volume of 1,222,850. Privia Health Group, Inc. has a 12 month low of $20.64 and a 12 month high of $37.98. The business has a fifty day simple moving average of $26.02 and a 200 day simple moving average of $26.35. The company has a market capitalization of $2.67 billion, a P/E ratio of 87.37, a PEG ratio of 3.01 and a beta of 0.79.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.05 by $0.01. Privia Health Group had a return on equity of 6.36% and a net margin of 2.26%. The business had revenue of $413.35 million for the quarter, compared to the consensus estimate of $392.34 million. Equities research analysts predict that Privia Health Group, Inc. will post 0.22 EPS for the current fiscal year.

Institutional Trading of Privia Health Group

Several large investors have recently modified their holdings of PRVA. Ensign Peak Advisors Inc lifted its position in Privia Health Group by 1.3% during the 1st quarter. Ensign Peak Advisors Inc now owns 31,290 shares of the company’s stock worth $864,000 after acquiring an additional 400 shares during the last quarter. Renaissance Capital LLC boosted its stake in Privia Health Group by 2.5% during the 1st quarter. Renaissance Capital LLC now owns 16,997 shares of the company’s stock valued at $469,000 after purchasing an additional 410 shares during the period. HighMark Wealth Management LLC grew its holdings in Privia Health Group by 46.1% in the 1st quarter. HighMark Wealth Management LLC now owns 1,315 shares of the company’s stock valued at $36,000 after buying an additional 415 shares during the last quarter. Amalgamated Bank increased its position in Privia Health Group by 5.8% in the 4th quarter. Amalgamated Bank now owns 7,638 shares of the company’s stock worth $173,000 after buying an additional 418 shares during the period. Finally, American International Group Inc. lifted its holdings in shares of Privia Health Group by 2.3% during the fourth quarter. American International Group Inc. now owns 21,670 shares of the company’s stock worth $492,000 after buying an additional 487 shares during the last quarter. 92.40% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

PRVA has been the subject of a number of research reports. TD Cowen decreased their price objective on Privia Health Group from $44.00 to $35.00 and set an “outperform” rating for the company in a research report on Tuesday, August 15th. UBS Group lowered their price objective on shares of Privia Health Group from $35.00 to $32.00 and set a “buy” rating on the stock in a research report on Friday, August 18th. Finally, Evercore ISI began coverage on shares of Privia Health Group in a research report on Monday, June 12th. They issued an “outperform” rating and a $34.00 target price for the company. Ten investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $36.86.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.